Lorena Pérez Amill

Glyscend Therapeutics

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Eduardo Anguita Mandly

Professor (Profesor Titular)

Universidad Complutense de Madrid

SPAIN

View details

Manel Juan

Head of Immunology service/department

Hospital Clínic de Barcelona

SPAIN

View details

Alba Pérez Pons

University of Salamanca

SPAIN

View details

Julio Delgado

Head

Hospital Clínic de Barcelona

SPAIN

View details

Laura Sanz

Lab Head

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lorena Pérez Amill

Research Interests

Explore related searches

Contact this professor

Articles (10)

Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited

A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry

Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression

Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma

NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness

Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma

Natural killer cells in immunotherapy: Are we nearly there?

Collaborators (5)

Eduardo Anguita Mandly

Manel Juan

Alba Pérez Pons

Julio Delgado

Laura Sanz

Make your next move.